What You Should Know:
– Octagos Health, a provider of AI-powered cardiac device monitoring solutions raises $43M in Series B funding led by funds managed by Morgan Stanley Expansion Capital with continued participation from Mucker Capital and other strategic investors.
– The investment fuels Octagos Health’s mission to leverage artificial intelligence for transformative cardiac care and comprehensive patient monitoring.
AI-Powered Cardica Care
Octagos Health offers a cutting-edge AI platform designed for continuous monitoring and in-depth data analysis of patients with implanted cardiac devices, including pacemakers, defibrillators, and more. Their proprietary technology, Atlas AI, boasts high accuracy and sensitivity in detecting critical cardiac events. This translates to:
- Automated Physician Workflows: Atlas AI streamlines workflows for physicians by automating tasks, allowing them to focus on delivering personalized patient care.
- Informed Decisions & Improved Outcomes: By providing data-driven insights, Atlas AI empowers healthcare providers to make informed decisions and ultimately improve patient outcomes.
Comprehensive Platform for Cardiology Practices
Octagos Health’s platform offers a comprehensive suite of features designed for seamless integration into existing workflows:
- Electronic Health Record (EHR) Integration: Seamless integration with existing EHR systems ensures data accessibility for improved care coordination.
- Customizable Reporting Features: Customizable reporting allows healthcare providers to tailor reports for optimal clinical decision-making.
“By combining AI, patient services, and bidirectional EHR integration, the Octagos Health platform enables cardiologists to efficiently monitor patients, improve patient care, and enhance clinic economics. The funding will help us accelerate our growth across the US and expand into other critical areas of cardiac care, including ambulatory monitors, consumer wearables, and sleep. Our goal is to build a comprehensive AI-based clinical decision support engine for healthcare. We are thrilled to have Morgan Stanley Expansion Capital as our lead investor and the continued support of Mucker Capital. In a short period, we have grown from first servicing my cardiology clinic to becoming one of the largest cardiac remote monitoring companies that provides software and services,” said Dr. Shanti Bansal, cardiologist, CEO of Octagos Health and Houston Heart Rhythm.
